Company Filing History:
Years Active: 2022-2024
Title: Innovations of Atsushi Mikami
Introduction
Atsushi Mikami is a notable inventor based in Suita, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antisense oligonucleic acids. His work aims to address critical issues related to hepatotoxicity in therapeutic applications.
Latest Patents
Atsushi Mikami holds two patents related to antisense oligonucleic acids. The first patent focuses on providing an antisense oligonucleic acid with reduced hepatotoxicity. This invention is characterized by a base length of not less than 7 nucleotides and not more than 30 nucleotides. It specifies that nucleic acid residues of not less than 1 nucleotide and not more than 5 nucleotides from both terminals are 2',4′-bridged nucleic acids. Additionally, 2′,4′-non-bridged nucleic acid residues are present between the terminals, with modifications in one or more bases of the non-bridged residues.
Career Highlights
Atsushi Mikami is affiliated with Osaka University, where he continues to advance his research in the field of molecular biology. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and application of antisense technology.
Collaborations
He has collaborated with notable colleagues such as Satoshi Obika and Reiko Waki. Their joint efforts have further enhanced the research and development of new therapeutic strategies.
Conclusion
Atsushi Mikami's work in the field of antisense oligonucleic acids represents a significant advancement in biotechnology. His innovative patents and collaborations highlight his commitment to improving therapeutic outcomes.